BNET Industries
Market Cap:$4.0B
Last Fiscal Year Sales:$2.5B
- Public
- US
Dow Jones Description
Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).
Number of Employees 5,070
Contact Information
311 Bonnie Cir
PO Box 1900
Corona, California 92880
(951) 270-1400
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Watson’s Rozerem ANDA Prompts Takeda Suit
-
Piper Jaffray Initiates Coverage on Watson Pharmaceuticals WPI with an Underweight; Hard to Envision Significant...
-
Takeda Sues Watson Over Generic Rozerem ANDA
-
FTC Proposes Asset Divestiture in Watson Acquisition of Arrow
-
Watson Completes Acquisition of Arrow Group
-
Trubion CEO out in management shuffle
-
Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research...
-
Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
-
Watson Pharmaceuticals names new senior vice president and CFO
-
UPDATE 1-Watson names R. Todd Joyce as new CFO
News & Analysis
Filter by
seeking alpha and watson pharmaceuticals inc. - All News and Analysis
Watson Pharmaceuticals Q3 2009 Earnings Call Transcript
Seeking Alpha
- 2009-11-04
Question-and-Answer SessionOperator (Operator's Instructions) Our first question comes from the line of Tim Chiang with FTN Equity. Tim Chiang - FTN Equity Thanks, Paul. Good morning. I wanted to ask you about the metoprolol launch. How has that gone? Did you have significant revenues...
Watson Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript
Seeking Alpha
- 2009-07-29
Question-and-Answer SessionOperator Operator instructions Your first question comes from Randall Stanicky from Goldman Sachs. Bob - Goldman Sachs Hi, good morning guys. This is actually Bob [ph] on for Randall this morning. Paul just quickly on the guidance, I guess could you may be help us understand, what gives...
Watson Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript
Seeking Alpha
- 2009-05-04
Earnings Call ExcerptWatson Pharmaceuticals, Inc. WPI Q1 2009 Earnings Call April 30, 2009 08:30 am ET Executives Patty Eisenhaur - Executive Director IR Paul Bisaro - President and CEO Mark Durand - CFO David Buchen - General Counsel Analysts Marc Goodman - UBS Greg Gilbert - Banc of America...
Watson Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript
Seeking Alpha
- 2009-02-19
Question-and-Answer SessionOperator Operator instructions We’ll pause for just a moment to compile the Q&A roster. Your question comes from Greg Gilbert with Bank of America. Paul Bisaro Hey, Greg. Greg Gilbert – Bank of America Hey, thanks. Good morning. Paul, you slipped in a comment about pricing improving, given...
Watson Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha
- 2008-10-29
Question-and-Answer Session Operator Yes, Ma’am. [Operator instructions] Your first question comes from the line of Tim Chang with FTN Midwest Reasearch. Tim Chang I just wanted to get an update on the generic pipeline, I think you just sort of mentioned one of the key products in that...
- 1
Industry Transcripts by Seeking Alpha
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
Glass Door
Watson Pharmaceuticals
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express